Expertise in
12
conditions

Regis Bordet

UCL Queen Square Institute Of Neurology, 
London, ENG, GB 
Expertise in
12
conditions
UCL Queen Square Institute Of Neurology, 
London, ENG, GB 

Overview

Regis Bordet practices practicing medicine in London, United Kingdom.

Mr. Bordet is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Stroke, Vascular Dementia, and Thrombectomy.

He is actively involved in clinical research, co-authoring 281 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

UCL Queen Square Institute Of Neurology, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Effect of a 15-day Memantine Treatment on Biomarkers of AD in Healthy Volunteers
Effect of a 15-day Memantine Treatment on Biomarkers of AD in Healthy Volunteers
Enrollment Status: Terminated
Publish Date: May 05, 2026
Intervention Type: Drug
Study Drug: Memantine
Study Phase: Phase 1
Controlled Education Of Patients After Stroke
Controlled Education Of Patients After Stroke
Enrollment Status: Completed
Publish Date: December 16, 2025
Intervention Type: Other
Study Phase: Not Applicable
Characterization of Clinical, Biological, Morphological and Pharmacological Factors Influencing Occurrence of Dementia or Cognitive Disorders After Stroke
Characterization of Clinical, Biological, Morphological and Pharmacological Factors Influencing Occurrence of Dementia or Cognitive Disorders After Stroke
Enrollment Status: Completed
Publish Date: December 16, 2025
View 2 Less Clinical Trials

281 Total Publications

Comparison of the effect of donepezil and a combination of donepezil and mefloquine (THN201) on cognition during a scopolamine challenge in healthy participants.
Comparison of the effect of donepezil and a combination of donepezil and mefloquine (THN201) on cognition during a scopolamine challenge in healthy participants.
Journal: Experimental and clinical psychopharmacology
Published: April 16, 2026

Frequently Asked Questions about Regis Bordet

Is Regis Bordet a top-rated expert for Dementia?

MediFind is an objective health platform that identifies experts based on real-world data. Regis Bordet is classified as an Distinguished expert for Dementia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Regis Bordet participate in research or clinical trials?

Yes. Regis Bordet has published 281 articles and abstracts on conditions like Dementia. You can view a list of Regis Bordet's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bordet's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile